<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02843984</url>
  </required_header>
  <id_info>
    <org_study_id>PRUa1GR-2013-00000220-B</org_study_id>
    <nct_id>NCT02843984</nct_id>
  </id_info>
  <brief_title>Influence of Vaginal Lactoferrin on Amniotic Fluid Cytokines to Avoid Pregnancy Complications</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Università degli Studi di Ferrara</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Università degli Studi di Ferrara</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Objective: To evaluate the influence of vaginal Lactoferrin administration on amniotic fluid
      concentration of 47 cytokines, chemokines and growth factors.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      60 women undergoing genetic amniocentesis will be enrolled at the Obstetric Unit, University
      of Ferrara. The selected patients will be randomly assigned to receive 300 mg of vaginal
      Lactoferrin to obtain 3 groups: A, 20 untreated patients; B and C (20 patients each one)
      respectively treated 4 and 12 h before amniocentesis. Cytokines, chemokines and growth
      factors concentrations will be quantified by a magnetic bead Luminex multiplex immunoassays
      panel technology.

      Amniotic fluid samples will be obtained by transabdominal amniocentesis and the sample not
      required for clinical purposes will be centrifuged to remove particulate material and the
      supernatants will be aliquoted and stored at -80°C until assay.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2011</start_date>
  <completion_date type="Actual">March 2012</completion_date>
  <primary_completion_date type="Actual">March 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Amniotic fluid concentration of mediators involved in inflammation</measure>
    <time_frame>1 month after the enrollment of patients will be concluded.</time_frame>
    <description>The investigator will measure the amniotic fluid concentration of 47 mediators (cytokines, chemokines and growth factors) involved in the inflammatory process by Luminex multiplex immunoassays. Controls and Lactoferrin-treated patients will be compared by parametric or non-parametric statistical tests.</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">60</enrollment>
  <condition>Pregnancy</condition>
  <arm_group>
    <arm_group_label>A - untreated</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>The patients will be not treated with vaginal lactoferrin</description>
  </arm_group>
  <arm_group>
    <arm_group_label>B - 4 hrs treatment</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The patients will be administered with a single dose of 300 mg vaginal lactoferrin 4 hours prior to mid-trimester genetic amniocentesis.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>C - 12 hrs treatment</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The patients will be administered with a single dose of 300 mg vaginal lactoferrin 12 hours prior to mid-trimester genetic amniocentesis.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Lactoferrin</intervention_name>
    <arm_group_label>B - 4 hrs treatment</arm_group_label>
    <arm_group_label>C - 12 hrs treatment</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  singleton physiological pregnancy;

          -  maternal age as the only indication to foetal karyotyping

        Exclusion Criteria:

          -  assumption of drugs interfering with the immune system;

          -  previous miscarriages;

          -  pregnancy at risk for maternal or foetal disease;

          -  lactose intolerance.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>25 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Obstetric Unit, University of Ferrara</name>
      <address>
        <city>Cona</city>
        <state>Ferrara</state>
        <zip>44124</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>July 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 19, 2016</study_first_submitted>
  <study_first_submitted_qc>July 21, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 26, 2016</study_first_posted>
  <last_update_submitted>July 21, 2016</last_update_submitted>
  <last_update_submitted_qc>July 21, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 26, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Università degli Studi di Ferrara</investigator_affiliation>
    <investigator_full_name>Alessandro Trentini</investigator_full_name>
    <investigator_title>PhD</investigator_title>
  </responsible_party>
  <keyword>Amniocentesis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pregnancy Complications</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lactoferrin</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

